Greenbrook TMS, Inc. (GBNH)
| Market Cap | 158.84M |
| Revenue (ttm) | 43.13M |
| Net Income (ttm) | -29.66M |
| Shares Out | 13.50M |
| EPS (ttm) | -2.32 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | April 21 |
| Last Price | $11.70 |
| Previous Close | $12.00 |
| Change ($) | -0.30 |
| Change (%) | -2.50% |
| Day's Open | 12.02 |
| Day's Range | 11.70 - 11.70 |
| Day's Volume | 315 |
| 52-Week Range | 11.55 - 15.87 |
TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), will release its first quarter 2021 operational and financial results after market hours on May 1...
TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), today announced its fourth quarter 2020 (“Q4 2020”) and year-end 2020 (“Fiscal 2020”) operational...
About GBNH
Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation therapy, an FDA-cleared non-invasive therapy for the treatment of depression and related psychiatric services. The company operates approximately 128 treatment centers. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.
| Industry Medical Care Facilities | Founded 2011 |
| Stock Exchange NASDAQ | Ticker Symbol GBNH |
Financial Performance
In 2020, Greenbrook TMS's revenue was $43.13 million, an increase of 20.86% compared to the previous year's $35.69 million. Losses were -$30.40 million, 91.8% more than in 2019.